Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Quanscient | $5,667,883 | (Nov 5, 2024)
ConKay Medical Systems, Inc.
United States
- Pleasanton
- 19/03/2024
- Seed
- $1,800,000
ConKay Medical Systems is an early-stage medical device company advancing unique solutions to treat valvular regurgitation in patients with progressive heart failure. Valvular regurgitation is when your valves do not close properly allowing blood to flow backwards in your heart causing shortness of breath, chest pain, and sometimes death. There are over 100 million people currently affected globally with valvular disease and an additional 5M Americans are diagnosed each year. ConKay’s annular repair technology is designed to treat the main cause of functional regurgitation leaving the healthy leaflets intact to perform the way it was intended. We are currently focused on the Tricuspid valve. Message us for more information!
- Industry Medical Equipment Manufacturing
- Website https://www.conkaymedical.com/
- LinkedIn https://www.linkedin.com/company/conkay-medical-systems-inc/
Related People
Albert YuanFounder
United States -
Pleasanton, California
Experience in leading and managing teams to design and develop minimally invasive medical devices.
Specialties:
Catheter Development and Design, Drug Eluting Stents, Angioplasty devices, Percutaneous devices for Mitral Valve Regurgitation, Drug coated balloons, Stent Retention, Vessel Closure Devices, Validation, Rapid prototyping, Bioabsorbable Coatings, Bioabsorbable materials, Biomaterials, System Based Failure and Risk Analysis, Test Method Development
Skills:
Solidworks, AutoCAD, Visual Basic, LabView, Minitab, PLC Programming, JMP statistical software, DOE, C++ Programming, Microsoft Office, PCR, Gel Electrophoresis, Knowledge of SOP, GLP, GMP and GDP procedures
Miros | $6,535,520 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Inquis Medical, Inc. | $40,000,000 | (Nov 5, 2024)
CrossBridge Bio | $10,000,000 | (Nov 5, 2024)